Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
about
Microbiome, Metabolome and Inflammatory Bowel DiseaseHLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populationsGenetic predictors of medically refractory ulcerative colitisColonic bacteria express an ulcerative colitis pANCA-related protein epitopeLack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis.Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?Perinuclear anti-neutrophil cytoplasmic antibodies (p-anca) in chronic ulcerative colitis: experience in a Mexican institution.Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease.Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody.Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitisBiased JH usage in plasma cell immunoglobulin gene sequences from colonic mucosa in ulcerative colitis but not in Crohn's disease.Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses.Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics.Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population.Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studiesInflammatory bowel disease: genetic and epidemiologic considerationsBacterial flagellin is a dominant antigen in Crohn disease.Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis.Serological markers to differentiate between ulcerative colitis and Crohn's disease.Epidemiology of inflammatory bowel disease: an update.P-ANCA in monozygotic twins with inflammatory bowel disease.Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers.TNFRSF1B Is Associated with ANCA in IBD.Association of HLA class-II genes and anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease.A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease.Long-term observation of the perinuclear anti-neutrophil cytoplasmic antibody status in ulcerative colitis patients.Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease.
P2860
Q28078126-E67167BF-ED10-4CF0-A22E-4C854A4F8F21Q28145401-D6BABB1F-6A31-45D0-AAB3-9B78E5FBD76DQ28943368-F37CE4F9-CEC1-47A4-92EA-C8546A561A22Q31518042-75030ECA-F666-42BB-A1F7-95BB215D5F9CQ33618092-327B22E1-8F21-41AF-B534-33CD85B17820Q33640438-D52FDFAE-7365-46C1-9ABF-E937D55AA5F8Q33867983-8E141FC1-39B8-4BC8-8FEE-FF984E167327Q34002778-7B3A80E0-2EB2-45E5-ABFC-AAEF333A11F4Q34009198-21E341A7-DC01-42FD-9EA4-3E155E49FC7BQ34012623-E50E92D2-3906-4B93-AC07-62B2360D8142Q35354348-BDFC50E0-DD03-4B47-A120-34235B867BE6Q35354820-49EF6C39-6A22-4B5E-9DAC-C52F3AAE5D11Q35358278-E22E4174-2F22-433C-8198-DC303341503EQ35361496-FEC2E6D1-8BD9-4E61-9211-F1EFD4CDE501Q35595367-AE57B3E0-DDCC-45B9-854B-54096C08E215Q36620188-A6505B4D-24B7-47A5-B0DC-564DA50BDD1BQ37058856-386D1C38-47A9-46FD-9973-450E7378CE0DQ37698878-AD9BC617-B7F9-4A97-97E4-61C39224D643Q38288749-D7ACB637-8E45-44D9-BDED-A433A1399CF8Q39646627-B953247D-A612-412A-B1D9-656E75459DF8Q41058402-F158E948-0C24-4973-BEBD-49A37F9E3CD3Q41676412-12B04C38-2073-4A3B-B1E2-131C8B6E04B9Q41702701-0DFC4E53-1E8E-4BE2-A6CE-5C43087B2CD5Q44920369-5A547F46-A0EF-4195-AF76-3DD0A89F1C5AQ47821308-6A5AB93F-7A1B-475E-823E-8E70230668E1Q48014912-47A5C7D4-DC6E-4AA7-9103-38B6E19D11ECQ50900409-22E9D5A9-2691-466B-86F5-74845478EF48Q51674064-5AC3AD78-17C3-40BC-B9C2-1D8155482E85
P2860
Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Ulcerative colitis: a genetica ...... toplasmic antibodies) markers.
@ast
Ulcerative colitis: a genetica ...... toplasmic antibodies) markers.
@en
Ulcerative colitis: a genetically heterogeneous disorder defined by genetic
@nl
type
label
Ulcerative colitis: a genetica ...... toplasmic antibodies) markers.
@ast
Ulcerative colitis: a genetica ...... toplasmic antibodies) markers.
@en
Ulcerative colitis: a genetically heterogeneous disorder defined by genetic
@nl
prefLabel
Ulcerative colitis: a genetica ...... toplasmic antibodies) markers.
@ast
Ulcerative colitis: a genetica ...... toplasmic antibodies) markers.
@en
Ulcerative colitis: a genetically heterogeneous disorder defined by genetic
@nl
P2093
P2860
P356
P1476
Ulcerative colitis: a genetica ...... toplasmic antibodies) markers.
@en
P2093
C K McElree
J I Rotter
S R Targan
P2860
P304
P356
10.1172/JCI116613
P407
P577
1993-08-01T00:00:00Z